Intranasal LHRH agonist (Buserelin) after ovulation:  a post-coital contraceptive approach.
D001695:Biology; D006063:Chorionic Gonadotropin; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D003338:Corpus Luteum; D004467:Economics; D004703:Endocrine System; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D006062:Gonadotropins; D006728:Hormones; D003341:Luteolysis; D010053:Ovary; D010827:Physiology; D010906:Pituitary Hormone-Releasing Hormones; D012102:Reproductive Control Agents; D012106:Research; D013672:Technology; D014566:Urogenital System
D006063:Chorionic Gonadotropin; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D006062:Gonadotropins; D006728:Hormones; D010906:Pituitary Hormone-Releasing Hormones; D012102:Reproductive Control Agents
Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Postcoital; Corpus Luteum; Economic Factors; Endocrine System; Family Planning; Genitalia; Genitalia, Female; Gonadotropins; Gonadotropins, Chorionic; Hormones; Luteolytic Effects; Ovary; Physiology; Pituitary Hormone Releasing Hormones; Reproductive Control Agents; Research And Development; Technology; Urogenital System